COMMUNIQUÉS West-GlobeNewswire

Align Technology Launches Treatment Planning Facility in Spain
07/09/2018
The newly opened facility will add 130 jobs in 2018, provide local support to Invisalign trained doctors in Spain and Portugal MADRID, Spain and SAN JOSE, Calif., Sept. 07, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc [...]
HealthLynked Corp. Announces Release of Group Chat Functionality Allowing Patients to Discuss Healthcare Topics in Real-time with Other Patients and Healthcare Professionals
07/09/2018
NAPLES, Fla., Sept. 07, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB: HLYK) today announced the release of its real-time chat software. HealthLynked’s new chat software allows its patient/users to join existing [...]
ProQR Prices $90.6 Million Underwritten Public Offering of Ordinary Shares
07/09/2018
LEIDEN, Netherlands and CAMBRIDGE, Mass., Sept. 07, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR), a biopharmaceutical company dedicated to changing lives through the creation of transformative RNA [...]
Management Board of JSC Olainfarm: Olainfarm will continue its development as intended by V. Maligins
07/09/2018
The Board of JSC "Olainfarm" informs that the newly elected company's Council and the Board constructively cooperate, and the first joint meeting took place already on September 4. The Council of the Company discussed [...]
Solon Eiendom ASA – Primary insider notification
07/09/2018
(Oslo, Norway, September 6, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg has today through his wholly owned company Dukat AS bought 15.000 shares in Solon Eiendom ASA at a price of NOK 28.1659. Following [...]
Oasmia completes a private placement of new convertible instruments in the amount SEK 35.2 million
07/09/2018
Oasmia Pharmaceutical AB (publ) (“Oasmia” or the “Company”) hereby announces that the Company has completed a private placement of a convertible loan in the total amount of SEK 35,200,000 with an interest rate of 8 per [...]
DBV Technologies : Reports First Half 2018 Financial Results
07/09/2018
Montrouge, France, September 7, 2018 DBV Technologies Reports First Half 2018 Financial Results DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical [...]
DBV Technologies : Résultats financiers du premier semestre 2018
07/09/2018
Montrouge, France, le 7 septembre 2018 (7H30 CEST) DBV Technologies résultats financiers du premier semestre 2018 DBV Technologies (Euronext: DBV - ISIN : FR0010417345 - NASDAQ : DBVT), société biopharmaceutique [...]
Pediapharm Announces Transformative Acquisitions and $60 Million Offering of Subscription Receipts
07/09/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. MONTREAL, Sept. 06, [...]
Clearside Biomedical Further Strengthens Commercial Organization With Appointment of Lester Rodríguez as Vice President, Quality
06/09/2018
ALPHARETTA, Ga., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
Neon Therapeutics to Present at Morgan Stanley 16th Annual Global Healthcare Conference
06/09/2018
CAMBRIDGE, Mass., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced that management will [...]
Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
06/09/2018
WALTHAM, Mass., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq:RDUS) today announced that the Company’s Board of Directors granted Dr. Charles Morris, in connection with his [...]
Profound Medical Files Preliminary Base Shelf Prospectus
06/09/2018
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES TORONTO, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”) announced today that [...]
Zealand sells royalty streams and milestones for USD 205 million to Royalty Pharma
06/09/2018
Company announcement - No. 21/ 2018 Zealand sells royalty streams and milestones for USD 205 million to Royalty Pharma Copenhagen, September 6, 2018 - Zealand Pharma A/S ("Zealand") (NASDAQ: ZEAL), a Copenhagen-based [...]
IRIDEX Announces FDA Clearance to Introduce Updated TruFocus LIO Premiere™ Laser Accessory to the U.S. Market
06/09/2018
MOUNTAIN VIEW, Calif., Sept. 06, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the introduction of its updated TruFocus LIO Premiere™ laser accessory following U.S. Food and Drug [...]
GBT Announces New Employment Inducement Grants
06/09/2018
SOUTH SAN FRANCISCO, Calif., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that, on September 4, 2018, the compensation committee of the Company’s board of [...]
Institutional Shareholder Services (ISS), Leading Proxy Advisor, Recommends Medigus Shareholders Vote “FOR” all Medigus’ Director Nominees
06/09/2018
-Medigus Implores Stockholders to Protect the Value of Their Investment and Vote “FOR” Medigus’ Director Nominees on the WHITE Proxy Card- OMER, Israel, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (“Medigus” or the [...]
Ascendis Pharma A/S Announces Presentations on Technology and Rare Disease Endocrinology Pipeline at September Conferences
06/09/2018
COPENHAGEN, Denmark, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technology to address significant unmet medical needs, today [...]
Replimune Announces FDA Acceptance of Investigational New Drug Application for its Lead Oncolytic Immunotherapy Candidate, RP1
06/09/2018
WOBURN, Mass., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Replimune Group Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immunotherapies derived from its Immulytic™ platform, today announced the U.S. Food and [...]

Pages